Ivan Burkov
Principal @ Inkef
Ivan Burkov is a seed investor at Inkef focused on Therapeutics and Biotechnology. Ivan Burkov
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ivan Burkov invests in
Stages Ivan Burkov invests in
Countries Ivan Burkov invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Country
- Denmark 1 (50%)
- The Netherlands 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Salvia BioElectronics develops innovative neuromodulation devices aimed at treating migraines. The company focuses on creating a paper-thin implant that delivers gentle electrical pulses to specific nerves, helping to alleviate migraine symptoms. Salvia BioElectronics is dedicated to advancing its technology through ongoing research and developmentefforts. With recent funding, the company works to bring its migraine therapy to market, offering a new approach to pain management for patients. The emphasis is on improving patient outcomes through effective neuromodulation therapy. | $60.1M / Series B / May 27, 2025 | ||
| Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, and advanced carbohydrate chemistry. The company isable to synthesize, screen, and select highly potent and specific heparan sulfate glycomimetic drug candidates in cardiovascular, inflammatory, and infectious diseases. | $13.2M / Seed / Jul 17, 2024 |
Co-Investors
About Inkef
Inkef is a venture capital firm based in Amsterdam, backing promising early stage companies in Europe. Inkef takes pride in being a patient, long-term investor with the ability to support companies through several rounds of funding. From the early stages of a technology or life science venture, Inkef supports entrepreneurs building their ideas intosuccessful international businesses.Investment areas: Technology and Healthcare
Inkef Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Frank Lansink
Partner
|
|||
|
Thijs Cohen Tervaert
Partner
|
|||
|
Derk Arts
Founder
|
|||
|
Ivan Burkov
Principal
|
|||
|
Simone Botti
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ivan Burkov invest in?
Ivan Burkov invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ivan Burkov?
Public channels for Ivan Burkov include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ivan Burkov last invest?
The most recent investment recorded for Ivan Burkov closed in May 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!